Skip to Main Content

Hired someone new and exciting? Promoted a rising star? Finally solved that hard-to-fill spot? Share the news with us, and we’ll share it with others. That’s

Katie Peng
Katie Peng Denali Therapeutics

right. Send us your changes, and we’ll find a home for them. Don’t be shy. Everyone wants to know who is coming and going.


And here is our regular feature in which we highlight a different person each week. This time around, we note that Denali Therapeutics (DNLI) hired Katie Peng as chief commercial officer. Previously, she was a senior vice president at Genentech, where she headed the OMNI business unit and was responsible for the neurology, ophthalmology, immunology, respiratory and rare diseases portfolio.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


Create a display name to comment

This name will appear with your comment

There was an error saving your display name. Please check and try again.